Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by <i>Geotrichum candidum</i> CCT 1205 and 
                        <i>Rhodotorula glutinis</i>  CCT 2182

<table>Prelog rule for discrimination of the faces of carbonylic group by the enzymes.</table>

Enzyme Research

fig1

Figure 1

Figure 1: Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by <i>Geotrichum candidum</i> CCT 1205 and 
                        <i>Rhodotorula glutinis</i>  CCT 2182 

Figure 1 | Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and 
                        Rhodotorula glutinis  CCT 2182 

Enzyme Research

Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and Rhodotorula glutinis CCT 2182

Figure 1